An immunohistochemical analysis to validate the rationale behind the enhanced immunogenicity of D-ribosylated low density lipo-protein

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Akhter, Firoz ^a   Khan, M Salman ^a   Singh, Sarika ^b   Ahmad, Saheem ^a  

^a INTEGRAL UNIVERSITY   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALKADIENE; CONJUGATE DIENE; DEXTRO RIBOSYLATED LOW DENSITY LIPOPROTEIN; FREUND ADJUVANT; HYDROXYL RADICAL; IMMUNOGLOBULIN G ANTIBODY; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; RIBOSE; SUPEROXIDE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG; ADVANCED GLYCATION END PRODUCT; ANTIGEN ANTIBODY COMPLEX;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY AFFINITY; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGENICITY; ARTICLE; CHEMICAL MODIFICATION; COMPETITIVE ENZYME LINKED IMMUNOSORBENT ASSAY; CONTROLLED STUDY; CROSS REACTION; DIRECT BINDING COMPETITIVE ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS BASEMENT MEMBRANE; GLYCATION; HISTOPATHOLOGY; IMMUNE COMPLEX DEPOSITION; IMMUNIZATION; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; NEW ZEALAND WHITE (RABBIT); NONHUMAN; VALIDATION PROCESS; ANIMAL; ANTIGEN ANTIBODY COMPLEX; CHEMICALLY INDUCED; IMMUNE COMPLEX DISEASE; IMMUNOLOGY; PATHOLOGY; RABBIT;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; FEMALE; GLOMERULAR BASEMENT MEMBRANE; GLYCOSYLATION END PRODUCTS, ADVANCED; IMMUNE COMPLEX DISEASES; LIPOPROTEINS, LDL; RABBITS; RIBOSE;

EID: 84911905356     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113144     Document Type: Article

References (42)

1. Gillery P, Jenison S (2014) Post-translational modification derived products (PTMDPs): toxins in chronic diseases? Clin Chem Lab Med 52(1): 33-38.
2. Lapolla A, Traldi P, Fedele D (2005) Importance of measuring products of non-enzymatic glycation of proteins. Clin Biochem 38: 103-115.
3. Goldin A, Beckman JA, Schmidt AM, Creager MA (2006) Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury. Circulation 114: 597-605.
4. Ahmad S, Shahab U, Baig MH, Khan MS, Khan MS, et al. (2013) Inhibitory effect of metformin and pyridoxamine in the formation of early, intermediate and advanced glycation end-products. PLoS One 8(9): e72128.
5. Azevedo M, Falcao J, Raposo J, Manso C (1988) Free Radic Res Commun 4: 331-335.
6. Mironova M, Virella G, Virella-Lowell I, Lopes-Virella MF (1997) Antimodified LDL antibodies and LDL-containing immune complexes in IDDM patients and healthy controls. Clin Immunol Immunopath 85: 73-82.
7. Akanji AO, Abdella N, Mojiminiyi OA (2002) Determinants of glycated LDL levels in nondiabetic and diabetic hyperlipidaemic patients in Kuwait. Clin Chim Acta 317(1-2): 171-176.
8. Lundberg AM, Hansson GK (2010) Innate immune signals in atherosclerosis. Clin Immunol 134: 5-24.
9. Andersson J, Libby P, Hansson GK (2010) Adaptive immunity and atherosclerosis. Clin Immunol 134: 33-46.
10. Lopes-Virella MF, Virella G (2010) Clinical significance of the humoral immune response to modified LDL. Clin Immunol 134: 55-65.
11. Saad AF, Virella G, Chassereau C, Boackle RJ, Lopes-Virella MF (2006) OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages. J Lipid Res 47: 1975-1983.
12. Lopes-Virella MF, McHenry MB, Lipsitz S, Yim E, Wilson PF, et al. (2007) Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes. Atherosclerosis 190: 359-369.
13. Yishak AA, Costacou T, Virella G, Zgibor J, Fried L, et al. (2006) Novel predictors of overt nephropathy in subjects with type 1 diabetes. A nested case control study from the Pittsburgh Epidemiology of Diabetes Complications cohort. Nephrol Dial Transplant 21: 93-100.
14. Kummu O, Turunen SP, Wang C, Lehtimäki J, Veneskoski M (2013) Carbamyl adducts on low-density lipoprotein induce IgG response in LDLR-/- mice and bind plasma autoantibodies in humans under enhanced carbamylation. Antioxid Redox Signal 19(10): 1047-1062.
15. Steinberg D (2009) The LDL modification hypothesis of atherogenesis: an update. J Lipid Res 50: S376-S381.
16. Ahmad S, Akhter F, Moinuddin, Shahab U, Khan MS (2013) Studies on glycation of human low density lipoprotein: A functional insight into physicochemical analysis. Int J Biol Macro 62: 167-171.
17. Akhter F, Khan MS, Shahab U, Ahmad S (2013) Bio-physical characterization of ribose induced glycation: A mechanistic study on DNA perturbations. Int J Biol Macromol 58: 206-210.
18. Beauchamp C, Fridovich I (1971) Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem 44: 276-287.
19. Halliwell B, Gutteridge JMC (1981) Formation of thiobarbituric acid-reactive substance from deoxyribose in the presence of iron salts: the role of superoxide and hydroxyl radicals. FEBS Lett 128: 347-352.
20. Moinuddin, Dixit K, Ahmad S, Shahab U, Habib S, et al. (2012) Human DNA damage by the synergistic action of 4-aminobiphenyl and nitric oxide: An immunochemical study. Environ Toxicol 29(5): 68-76.
21. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509.
22. Yagi K (1987) Lipid peroxides and human diseases. Chem Phus Lipids 45(2-4): 337-51.
23. Liu KT, Lesca P (1982) Pharmacological properties of Dibenzo[a, c]cyclooctene derivatives isolated from Fructus Schizandrae Chinensis III. Inhibitory effects on carbon tetrachloride-induced lipid peroxidation, metabolism and covalent binding of carbon tetra chloride to lipids. Chem Biol Interact 41(1): 39-47.
24. Shahab U, Ahmad S, Moinuddin, Dixit K, Habib S, et al. (2012) Hydroxyl Radical Modification of Collagen Type II Increases Its Arthritogenicity and Immunogenicity. PLoS ONE 7(2): e31199.
25. Shahab U, Moinuddin, Ahmad S, Dixit K, Habib S, et al. (2013) Genotoxic effect of N-hydroxy-4-acetylaminobiphenyl on human DNA: implications in bladder cancer. PLoS One 8(1): e53205.
26. Mustafa I, Ahmad S, Dixit K, Moinuddin, Ahmad J, et al. (2012) Glycated human DNA is a preferred antigen for anti-DNA antibodies in diabetic patients. Diabetes Res Clin Pract 95(1): 98-104.
27. Goding JW (1976) Use of staphylococcal protein-A as an immunological reagent. Immuol Methods 20: 241-253.
28. Shahab U, Moinuddin, Ahmad S, Dixit K, Abidi SMA, et al. (2012) Acquired Immunogenicity of Human DNA Damaged by N-Hydroxy-N-acetyl-4-aminobiphenyl. IUBMB Life 64(4): 340-345.
29. Cervantes-Laurean D, Minter DE, Jacobson EL, Jacobson MK (1993) Protein glycation by ADP-ribose: studies of model conjugates. Biochemistry 32(6): 1528-1534.
30. Kellar PJ, Kim SU, Bown DH, Chen HC, Kohnle A, et al. (1988) Biosynthesis of riboflavin: mechanism of formation of the ribitylamino linkage. Biochemistry 27: 1117-1120.
31. Lopes-Virella MF, Hunt KJ, Baker NL, Lachin J, Nathan DM, et al. (2011) Levels of Oxidized LDL and Advanced Glycation End Products-Modified LDL in Circulating Immune Complexes Are Strongly Associated With Increased Levels of Carotid Intima-Media Thickness and Its Progression in Type 1 Diabetes. Diabetes 60: 582-589.
32. Kortlandt W, Benschop C, van Rijn HJ, Erkelens DW (1992) Glycated low density lipoprotein catabolism is increased in rabbits with alloxan-induced diabetes mellitus. Diabetologia 35(3): 202-207.
33. Ahmad S, Moinuddin, Shahab U, Habib S, Salman Khan M, et al. (2014) Glycoxidative damage to human DNA: Neo-antigenic epitopes on DNA molecule could be a possible reason for autoimmune response in type 1 diabetes. Glycobiology 24(3): 281-291.
34. Ahmad S, Moinuddin, Habib S, Shahab U, Alam K, et al. (2014) Autoimmune response to AGE modified human DNA: Implications in type 1 Diabetes mellitus. J Clin. Trans. Endo. 1: 3; 66-72.
35. Ahmad S, Moinuddin, Dixit K, Shahab U, Alam K, et al. (2014) Genotoxicity and immunogenicity of DNA-advanced glycation end products formed by methylglyoxal and lysine in presence of Cu2+. Biochem Biophys Res Commun. 407(3): 568-574.
36. Shahab U, Tabrez S, Khan MS, Akhter F, Khan MS, et al. (2014) Immunogenicity of DNA-advanced glycation end product fashioned through glyoxal and arginine in the presence of Fe3+: its potential role in prompt recognition of diabetes mellitus auto-antibodies. Chemico Biol Int. 219; 229-240.
37. Ahmad MI, Ahmad S, Moinuddin (2011) preferential recognition of methylglyoxal modified calf thymus DNA by circulating autoantibodies in cancer patients. Ind Journal of Biochem and Biophys. 48: 290-296.
38. Rahim M, Iram S, Khan MS, Khan MS, Shukla AR, et al. (2013) Glycation-assisted synthesized gold nanoparticles inhibit growth of bone cancer cells. Colloids Surf B Biointerfaces 117: 473-479.
39. Ahmad S, Khan MS, Khan MS, Akhter F, Khan A, et al. (2014) Glycoxidation of biological macromolecules: A critical approach to halt the menace of glycation. Glycobiology 24: 979-990.
40. Iqbal D, Khan MS, Khan MS, Ahmad S, Srivastava AK (2013) An In Vitro and molecular informatics study to evaluate the antioxidative and β-hydroxy-β-methylglutaryl-CoA reductase inhibitory Property of Ficus virens Ait. Phytother Res doi:10.1002/ptr.5077.
41. Hashim A, Khan MS, Khan MS, Baig MH, Ahmad S (2013) Antioxidant and α-amylase inhibitory property of phyllanthus virgatus L.: an in vitro and molecular interaction study. Biomed Res Int doi:10.1155/2013/729393.
42. Akhter F, Hashim A, Khana MS, Ahmad S, Iqbal D, et al. (2013) Antioxidant, α-amylase inhibitory and oxidative DNA damage protective property of Boerhaavia diffusa (Linn.) root. S Afr J Biol 88: 265-272.